Journals / Retina-Vitreus / 2014 / Cilt: 22 - Sayı: 3

Outcome of heavy silicone oil in the management of retinal detachment with ınferior breaks

İnferior yırtıklı retina dekolmanı tedavisinde ağır silikon kullanılan olgulardaki sonuçlarımız

Pages
209–212
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It can be useful par- ticularly in disability of postoperative posturing, when the proliferative vitreoretinopathy risk is high, and when a rigorous posturing is necessary as in the case of inferior retinectomy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To assess the efficacy and safety of Densiron 68 in the management of retinal detachment with inferior breaks.
📊
Key Findings & Data:Results: Re-attachment was achieved in 18 cases of 19 with single PPV.(Success rate:95%) BCVA improved to 0.89±0.67 from 2.63±0.75 logMar after treatment.Complications such as intraocular pressure rise,cataract, inflammatory reaction, macular epiretinal membrane, emulsification of silicone were seen after treatment.
💡
Conclusion & Impact:It can be useful par- ticularly in disability of postoperative posturing, when the proliferative vitreoretinopathy risk is high, and when a rigorous posturing is necessary as in the case of inferior retinectomy.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To assess the efficacy and safety of Densiron 68 in the management of retinal detachment with inferior breaks. Material and Methods: The cases treated with PPV and Densiron for the management of retinal detachment with inferior breaks (RDWIB)were reviewed for stastistical analyses. Results: Re-attachment was achieved in 18 cases of 19 with single PPV.(Success rate:95%) BCVA improved to 0.89±0.67 from 2.63±0.75 logMar after treatment.Complications such as intraocular pressure rise,cataract, inflammatory reaction, macular epiretinal membrane, emulsification of silicone were seen after treatment. Conclusion: It can be emphasised that Densiron is efficient and safe in the management of RDWIB. It can be useful par- ticularly in disability of postoperative posturing, when the proliferative vitreoretinopathy risk is high, and when a rigorous posturing is necessary as in the case of inferior retinectomy.

Özet

Amaç: İnferior yırtıklı retina dekolmanı olgularında endotamponad olarak Densiron 68 kullanımının etkinlik ve güvenir- liğinin araştırılması. Gereç ve Yöntem: Saat dört ve sekiz arasında yırtığı olan retina dekolmanı olgularının tedavisi için yapılan pars plana vitrektomi (PPV) opersyonlarında endotamponad olarak Densiron kullanılan olguların dosyaları retrospektif olarak tara- nıp, elde edilen veriler istatistik analiz ile değerlendirildi. Bulgular: Ondokuz retina dekolmanı olgusunun 18’inde tek PPV girişimi ile başarı sağlandı. (Başarı oranı: %95) Tedavi ön- cesi 2.63±0.75 LogMar olan ortalama düzeltilmiş en iyi görme keskinliği tedavi sonrası 0.89±0.67 seviyesine geldi. GİB artışı, katarakt, inflamatuar reaksiyon, makülar epiretinal membran, silikon emulsifikasyonu gibi komplikasyonlar görüldü. Sonuç: Densiron’un inferior yırtıklı retina dekolmanı (İYRD) tedavisinde etkin ve güvenli bir entotamponad olduğu söyle- nebilir. Özellikle postoperatif postür zorluğu olan olgularda, proliferatif vitreoretinopati riskinin yüksek olduğu olgularda, inferior retinektomi gibi postoperatif postürün daha katı yapılması gereken durumlarda tercih edilebilir.

🔖

Cite This Article

KOÇAK, İ. (2014). Outcome of heavy silicone oil in the management of retinal detachment with ınferior breaks. Retina-Vitreus, Cilt: 22 - Sayı: 3, 209–212. https://ajindex.com/articles/305017

References (18)

  1. Gabel VP, Kampik A, Gabel CH, Spiegel D. Silicone oil with high specific gravity for intraocular use.Br J Ophthalmol 1987
  2. Fawcett IM, Williams RL, Wong D. Contact angles ofsub- stances used for internal tamponade in retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 1994
  3. Kertes PJ, Peyman GA. Use of silicone oil in vitreous sur- gery
  4. in Peyman GA, Meffert SA, Conway MD, Chou F (eds): Vitreoretinal surgical techniques. London, Martin Dunitz, 2001
  5. pp:193-206. 4.Campo RV, Sipperley JO, Sneed SR at al. Pars plana vitrec- tomy without scleral buckle for pseudophakic retinal detach- ments. Ophthalmology 1999
  6. Tanner V, Minihan M, Williamson TH. Management of infe- rior retinal breaks during pars plana vitrectomy for retinal detachment. Br J Ophthalmol 2001
  7. Sharma A, Grigoropoulos V, Williamson TH. Management of primary rhegmatogenous retinal detachment with inferior breaks. Br J Ophtalmol 2004
  8. Berker N, Batman C, Ozdamar C et al. Long term outcomes of heavy silicone oil tamponade for complicated retinal detach- ment. Eur J Ophthalmol 2007
  9. Tognetto D, Minutola D, Sanguinetti G, et al. Anatomical and functional outcomes after heavy silicone oil tamponade in vitreorertinal surgery for complicated retinal detachment
  10. a pilot study. Ophthalmology 2005
  11. Rizzo S, Belting C, Genovesi-Ebert F et al. Succesful treat- ment of persistent macular holes using ‘heavy silicone oil’ as intraocular tamponade. Retina 2006
  12. Benson T O, Cheung BTO, Lai TYY et al. Results of hig den- sity silicone oil as a tamponade agent in macular hole retinal detachment in patients with high myopia. Br J Ophthalmol 2007
  13. Boscia F, Furino C, Recchimurzo N, et al. OxaneHD vs sili- cone oil and scleral buckle in retinal detachment with prolif- erative vitreoretinopathy and inferior retinal breaks.Graefes Arch Clin Exp Ophthalmol 2008
  14. Er H. Primary heavy silicone oil usage in inferior rhegmatog- enous retinal detachment. Ophthalmologica 2010
  15. Kita M, Negi A, Kawano S, Honda Y. Photothermal, cryo- genic, and diathermic effects of retinal adhesive force in vivo. Retina 1991
  16. Holladay JT. Proper method for calculating average visual acuity. J Refract Surg 1997
  17. Asaria RH, Kon CH, Bunce C, et al. Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid. Br J Ophtalmol 2004
  18. Wong D, Van M